Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Interim report January-March 2019

January-March 2019 · Net sales for the first quarter amounted to SEK 3,469 million (3,173). · Organic growth was a negative 1 per cent (neg: 6). · Operating profit amounted to SEK 260 million (255), corresponding to an operating margin of 7.5 per cent (8.0). · Currency gains had an impact of approximately SEK 5 million on the Group’s operating profit, of which a positive SEK 10 million in translation effects and a negative SEK 5 million in transaction effects. · Profit after tax amounted to SEK 183 million (193), corresponding to earnings per share after dilution of SEK 1.

Artificial Solutions Drives Expansion in APAC with New Appointment

Stockholm, Sweden, 2 May 2019 – Artificial Solutions ® (FNSE:ASAI ), the leading specialist in enterprise-strength conversational AI, announced today the appointment of Chris Tew as VP Asia Pacific to drive growth in the region. Chris will head up the APAC team based in Singapore to support the increasing demand for Artificial Solutions award-winning conversational AI development platform, Teneo®. With a successful track record of establishing strong commercial operations throughout APAC, Chris will

Elkem ASA - Ex dividend NOK 2.60 today

Oslo, 2 May 2019 The shares in Elkem ASA will be traded ex dividend of NOK 2.60 as of today, 2 May 2019. This information is subject of the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act. For further information, please contact: Odd-Geir Lyngstad, VP Finance & Investor Relations Tel: +47 976 72 806 Email: odd-geir.lyngstad@elkem.no About Elkem ASAFounded in 1904, Elkem is one of the world's leading suppliers of silicon-based advanced materials with operations throughout the value chain from quartz to specialty silicones, as

Atlas Copco has acquired an engine service company in the US

Stockholm, Sweden, May 2, 2019: Atlas Copco has acquired Mid South Engine & Power Systems, LLC. The company is a leading provider of service for off-road engines and spare parts in the US Gulf Coast.Mid South is based in White Oak, Texas, USA and has 28 employees. The company has a second facility in Fort Worth, also in Texas, and mainly serves the oil and gas market in the US Gulf Coast. In 2018, the company had a turnover of MUSD 6 (MSEK 54). “Mid South has a strong reputation and capabilities to repair and refurbish portable compressors and engines”, said Andrew Walker, Business

Ortoma Engages M&A Advisor

Ortoma and the Board of Directors have engaged MedWorld Advisors (www.medworldadvisors.com) as M&A advisor to assist the company and the Board with management, evaluations, and negotiations in connection with any M&A transaction.During the past year, the company have had discussions with potential industrial partners as a part of taking its product Ortoma Treatment Solution to the market. MedWorld Advisors will take over the contacts that have been generated by the company, broaden and intensify the evaluation, and negotiate with potential acquirers and industrial partners. Linus Byström,

Vitrolife has received order for 20 EmbryoScope+ to leading clinic in China

In March, Vitrolife AB (publ) received market approval for the time-lapse incubator EmbryoScope+ in China. The company has now received order for 20 EmbryoScope+ to be installed at a leading clinic in China during the second quarter. The order is the largest single order for EmbryoScope+ so far for Vitrolife.EmbryoScope+ is a time-lapse system with an integrated incubator with a capacity for fifteen patients. Vitrolife is the market leader of time-lapse systems for use in assisted reproduction for undisturbed culture and improved selection of embryos. In March, Vitrolife received market

New CEO in place: Arne Norheim ready for Webstep

From May 2, Arne Norheim is the new chief executive officer of Webstep ASA. – I’m very pleased to get started. Webstep is an exciting company with committed and capable people. I’m looking forward to meeting everyone and getting to know the company from within. Together, we’ll accomplish much, he says.Arne Norheim is succeeding Kjetil Eriksen, who has headed the company since 2006. The new Webstep head’s career started in IBM ten years prior to that. Since 1996, Arne Norheim has held various positions within finance and administration in IBM, in the US, Sweden, France, and Denmark, before

Irisity advance the publication of the interim report Q1 and updates its financial calendar

In order to give the stock market an earlier and improved information about the company's development, the Board of Directors of Irisity AB (publ) has decided to advance the publication of the Q1 report and update the financial calendar for the current year. The interim report Q1 will be published on May 10 (previously 22/5) and the financial calendar for 2019 will be changed to the following: Q1 - May 10 (22/5) Q2 - August 6 (14/8) Q3 - November 5 (22/11) (previous date in parentheses) For further information: Marcus Bäcklund, CEO Phone: +46 733 80 17 80E-mail:

Booming interest for Sivers IMA’s 5G technology

Sivers IMA (Nasdaq First North: SIVE) today announced that they, together with partners, have sold more than 20 evaluation kits for 5G since the Mobile World Congress (MWC) in February.Sivers IMA (Nasdaq First North: SIVE) today announced that they, together with partners, have sold more than 20 evaluation kits for 5G since the Mobile World Congress (MWC) in February. The 5G test kits are a way for prospective customers to evaluate how Sivers IMA’s equipment works in order to design in Sivers IMA’s products in their next step. The total order value for these kits is not substantial,

XVIVO’s patents for the heart preservation fluid approved in the US and Europe

XVIVO’s patent for the heart preservation fluid has been approved in the US and Europe. Canada has already approved this patent. XVIVO has also previously received a patent for the heart evaluation equipment in Europe, Australia, Canada and China. The review of the patent application for the heart evaluation equipment is in its final stages in the US. Together these patents strengthen XVIVO’s position in the heart transplantation field on all major markets in the world.XVIVO has two main patents in the field of heart transplantation. The first of these covers the preservation fluid that is

Jon Sintorn new CEO of Nobia

After nine years as CEO of Nobia, one of Europe’s largest kitchen specialists with operations covering the entire value chain, Morten Falkenberg is stepping down from his position at the company. Morten Falkenberg, who is a Board member of the companies Velux Group and Fagerhult, will transition into new roles including industrial advisor for Nobia’s largest owner, Nordstjernan. Jon Sintorn, who most recently served as President and CEO of Permobil, will succeed Morten Falkenberg at the latest on September 1, 2019. Jon Sintorn has entered an agreement with Nordstjernan to acquire, today or

Stayhard and Round Two founder, Luke Fracher, in a unique design collaboration

Swedish online menswear store Stayhard is launching a collection in collaboration with fashion entrepreneur and sneaker specialist Luke "Mook" Fracher. Luke is, together with Sean Wotherspoon and Chris Russow, the founders of the esteemed streetwear resale stores Round Two, which has become a world phenomenon for a new generation buy-sell-trade consumers. The collection that will bring the Round Two hype to Sweden will release this May.The collaboration consists of a 17 piece strong collection that embodies Luke’s discerned fashion sense and personal sartorial point of view. Grails from his

First patient treated with C-RAD’s cutting-edge positioning system at the Cancer Care Center Negrar-Verona, Italy

C-RAD and Ospedale Sacro Cuore Don Calabria – the Cancer Care Center in Negrar-Verona - announced today that the first patient has been treated with C-RAD’s surface tracking system at the site. In Italy, the installation is with four C-RAD systems the largest single hospital installation and the first installation on Varian linear accelerators. Ospedale Sacro Cuore Don Calabria is a Research Institute (IRCCS) and the Cancer Care Center in Negrar-Verona. The installation of three Catalyst HD™ systems and one Sentinel 4DCT™ was completed beginning of April. The first patient treated was

Pharmacolog is expanding its product portfolio

Pharmacolog introduces two new product concepts based on its patented DrugLog® technology. WasteLog™ and PrepLog™ are newly developed solutions to specifically address the market for Drug Diversion and the market for drug controls in an integrated environment. The products are currently being developed but are expected to be fully launched in the latter part of 2019.Pharmacolog is engaged in the development and testing of two new product concepts, WasteLog™ and PrepLog™, both of which are based on the technology available in the current DrugLog® but with newly developed software. WasteLog™

Nordic Waterproofing updates its long-term financial targets as a result of the adoption of IFRS 16 and discontinued disclosure of items affecting comparability

The Board of Directors of Nordic Waterproofing Holding A/S (STO: NWG.ST) has updated the Group’s long-term financial targets following the adoption of the IFRS 16 Leases standard. In addition, the Board of Directors has decided to discontinue the disclosure of items affecting comparability.As a result of the adoption of IFRS 16 Leases standard as of January 1, 2019, and the discontinued disclosure of items affecting comparability, many key figures have been affected, e.g. EBITDA increased, ROCE-% decreased and net debt and net debt to EBITDA increased. Nordic Waterproofing therefore

Ex dividend NOK 3.25 today

The shares in Atea ASA will be traded ex dividend NOK 3.25  as from today, 02.05.2019. For further information, please contact:Steinar Sønsteby, CEO Atea ASA, mobile (+47) 930 55 655Robert Giori, CFO Atea ASA, mobile (+47) 934 09 188 About Atea Atea is the leading supplier of IT infrastructure and system integration in the Nordic and Baltic regions with more than 7,300 employees. Atea is present in 87 cities in Norway, Sweden, Denmark, Finland, Lithuania, Latvia and Estonia. Atea delivers IT products from leading vendors and assists its customers with specialist competencies

BONESUPPORT HOLDING AB (publ) – Published Q1 2019 Interim report

Lund, Sweden, 08.00 am CET, 2 May 2019 – BONESUPPORT™, listed on Nasdaq Stockholm - BONESUPPORT HOLDING AB (publ) - listed on Nasdaq Stockholm - an emerging leader in orthobiologics for the management of bone voids, today publish the financial report for thean emerging leader in orthobiologics for the management of bone voids, today published the interim report for the first quarter 2019. STRONG GROWTH FOR CERAMENT G AND CERAMENT V “The strategic changes initiated in 2018 begin to show results. Our antibiotic-eluting products grew by 54 percent in the quarter and we see a significant

The world’s largest communication network is moving to Hammarby Sjöstad, and Fabege

Publicis Media is a global communications network that is part of the Publicis Group, the world’s largest media and communications network. It is now signing an agreement with Fabege regarding a new office in Luma. The agreement has a duration of 6 years and relates to 2,900 square metres of office space with an annual rent of SEK 10.7m.Publicis Groupe is a French corporate group with over 80,000 employees and operations in over 100 countries. The group is now concentrating its Swedish operations, with more than 200 employees, in Hammarby Sjöstad, which involves co-locating companies such

Q1 report January – March 2019

Highlights first quarter 2019Net collections increased by 77% to EUR 18.9M (Q1 2018 EUR 10.7M)** Cash EBITDA increased by 95% and amounted to EUR 16.8M (Q1 2018: EUR 8.6M) Net profit for the period of EUR 0.0M (Q1 2018: EUR 1.0M) Gross ERC at the end of March 2019 was EUR 217M (Q4 2018: EUR 240M)*** Cash on hand available for investment at the end of March 2019 was EUR 63M (Q4 2018: EUR 60M) Secured super senior RCF of EUR 27M significantly lowering the cost of funding, priced at Euribor plus a margin of 350 basis points and available for period of up to two years Sale

CELLINK launches new tissue model kits

The new tissue model kits were developed to provide customers with tissue-specific bioinks and antibodies. The kits include antibodies from Atlas Antibodies, a collaborator with extensive experience in antibody development and production. CELLINK, the world’s first bioink company and a global leader in bioprinter systems and bioinks, continues innovating new ways to strengthen its position in the field.   Today, CELLINK is announcing the launch of two new tissue model kits — CELLINK SKIN Kit and CELLINK LIVER Kit. These kits give users valuable information about the phenotype of their

Q1 report January – March 2019

Highlights first quarter 2019 Net collections increased by 72% to EUR 18.1M (Q1 2018 EUR 10.5M)** Cash EBITDA increased by 85% and amounted to EUR 16.4M (Q1 2018: EUR 8.9M) Net loss for the period of EUR 0.5M (Q1 2018: profit of EUR 0.9M) Cash on hand available for investment at the end of March 2019 was EUR 61M (Q4 2018: EUR 57M) Secured super senior revolving credit facility of EUR 27M significantly lowering the cost of funding, priced at Euribor plus a margin of 350 basis points and available for a period of up to two years Sale of portfolios in Russia resulted in EUR

There are no items matching the current filter
There are no more items matching the current filter
Back to top